Institutional investors purchased a net $2.3 million shares of IPXL during the quarter ended June 2017 and now own 88.75% of the total shares outstanding. This majority interest is a greater percentage than is typical for companies in the Pharmaceuticals: Generic industry and highlights that the smart money sees this stock as an important holding.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
MAVERICK CAPITAL LTD. Bought 7.1 Million shares of Impax Laboratories Inc
BRIDGER MANAGEMENT LLC Bought 1.3 Million shares of Impax Laboratories Inc